Sangamo Therapeutics Competitors and Similar CompaniesClear all
Sangamo Therapeutics's competitors and similar companies include Bruker Cellular Analysis, Aldevron, Evotec, BlueRock Therapeutics and PhaseBio Pharmaceuticals.
 Sangamo Therapeutics Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies. |  Bruker Cellular Analysis Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products. |  Aldevron Aldevron is a company that specializes in manufacturing solutions and regulatory support for both viral and non-viral vector therapies. |  PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. | |||
Founding Date | Founding Date 1995 | Founding Date 2011 | Founding Date 1998 | Founding Date 1993 | Founding Date 2016 | Founding Date 2002 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public | Type Subsidiary | Type Public |
Tags | ||||||
Locations | Locations Brisbane, US HQ Nice Area, FR Cheltenham, GB London, GB Richmond, US | Locations Emeryville, US HQ | Locations Fargo, US HQ Madison, US | Locations Hamburg, DE HQ Lyon, FR Toulouse, FR Göttingen, DE Halle (Westfalen), DE Köln, DE Munich, DE see more | Locations Cambridge, US HQ Toronto, CA Berlin, DE New York, US | Locations Malvern, US HQ |
Employees | Employees 35417% increase | Employees 1391% decrease | Employees 8052% decrease | Employees 4,766 | Employees 477 | Employees 22 |
Valuation ($) | Valuation ($) 416.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) $39.6m (FY, 2025) | Revenue (est.) $78.6m (FY, 2022) | Revenue (est.) $300m (Y, 2020) | Revenue (est.) €788.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $10.8m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods $24.8m (FY, 2022) | Cost of goods N/A | Cost of goods €622.9m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $53.8m (FY, 2022) | Gross profit N/A | Gross profit €231.1m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($122.9m) (FY, 2025) | Net income ($98m) (FY, 2022) | Net income N/A | Net income (€103.5m) (FY, 2025) | Net income N/A | Net income ($131.1m) (FY, 2021) |
Operating ⚠ | ||||||
Customers | Customers N/A | Customers 80 (FY, 2021) | Customers N/A | Customers 781 (FY, 2023) | Customers N/A | Customers N/A |
New Customers | New Customers N/A | New Customers 22 (FY, 2020) | New Customers N/A | New Customers 298 (FY, 2023) | New Customers N/A | New Customers N/A |
Funding | ||||||
Total funding raised | Total funding raised $ 74.2m | Total funding raised $ 124.7m | Total funding raised N/A | Total funding raised $ 993.6m | Total funding raised $ 225m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Bruker Cellular Analysis
HQ
Emeryville, US
Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products.
View companyAldevron
HQ
Fargo, US
Aldevron is a company that specializes in manufacturing solutions and regulatory support for both viral and non-viral vector therapies.
View company
Evotec
HQ
Hamburg, DE
Employees
4,766
Evotec is a biotechnology company that provides drug discovery and development services.
View company
BlueRock Therapeutics
HQ
Cambridge, US
BlueRock Therapeutics is a biotechnology company that develops cell therapies.
View company